Evaluation of physical and chemical modifications to drug reservoirs for stimuli-responsive microneedles

Authors: Luchi Li (Queen's University Belfast), Qonita Kurnia Anjani (Queen's University Belfast), Aaron R. J. Hutton (Queen's University Belfast, University of Ulster), Mingshan Li (Queen's University Belfast), Akmal Hidayat Bin Sabri (Queen's University Belfast), Lalitkumar K. Vora (Queen's University Belfast), Yara A. Naser (Queen's University Belfast), Yushi Tao (Queen's University Belfast), Helen O. McCarthy (Queen's University Belfast), Ryan F. Donnelly (Queen's University Belfast)

Drug Delivery and Translational Research
DOI: 10.1007/s13346-024-01737-0 - DOI (Pharmacology, Toxicology and Pharmaceutics)
Published on 20 Nov. 2024
License: CC BY
Abstract

Abstract Hydrogel-forming microneedle (MN) arrays are minimally-invasive devices that can penetrate the stratum corneum, the main barrier to topical drug application, without causing pain. However, drug delivery using hydrogel-forming MN arrays tends to be relatively slow compared to rapid drug delivery using conventional needles and syringes. Therefore, in this work, for the first time, different physical and chemical delivery enhancement methods were employed in combination with PVA-based hydrogel-forming MN arrays. Using a model drug, ibuprofen (IBU) sodium, the designed systems were assessed in terms of the extent of transdermal delivery. Iontophoresis (ITP) and heat-assisted drug delivery technology were investigated as physical permeation enhancement techniques. Ex vivo studies demonstrated that the ITP (0.5 mA/cm2)-mediated combination strategy significantly enhanced the transdermal permeation of IBU sodium over the first 6 h (~ 5.11 mg) when compared to MN alone (~ 1.63 mg) (p < 0.05). In contrast, heat-assisted technology showed almost no promoting effect on transdermal delivery. Furthermore, IBU sodium-containing rapidly dissolving lyophilised and effervescent reservoirs, classified as chemical modification methods, were prepared. Both strategies achieved rapid and effective ex vivo IBU sodium permeation, equating to ~ 78% (30.66 mg) and ~ 71% (28.43 mg) from lyophilised and effervescent reservoirs, respectively. Moreover, in vivo pharmacokinetic studies showed that the IBU sodium plasma concentration within lyophilised and effervescent groups reached a maximum concentration (Cmax) at 4 h (~ 282.15 µg/mL) and 6 h (~ 140.81 µg/mL), respectively. These strategies not only provided rapid achievement of therapeutic levels (10–15 µg/ml), but also resulted in sustained release of IBU sodium for at least 48 h, which could effectively reduce the frequency of administration, thereby improving patient compliance and reducing side effects of IBU sodium. Graphical Abstract

The papers around it, by date and closeness

Higher is closer to this paper; left is older. Lines join papers close to each other: groups of lines are sub-topics. Select a point to see why it is there. Back to the summary of this paper

How to read this map? Illustrated guide

Closest papers Prior work it builds on Papers that cite it

Papers around this one

Ranked by how close their title and abstract are to this paper’s. Select some to read them together.

Closest papers

  1. Very close Builds on this paper Cites this paper
    Engineering and in vitro evaluation of semi-dissolving, hydrogel-forming polymeric microneedles for sustained-release drug delivery.
    T. Abdelghany, N. Vo, D. Vukajlovic et al. · 2025 · International journal of pharmaceutics · cited 12 times · Not summarized yet

    Engineering semi-dissolving polymeric microneedles for sustained release, extending the hydrogel-forming microneedle delivery approach.

    Abstract

    Polymeric microneedle array patches (MAPs) offer a painless and convenient way for delivering drugs across various biological membranes, including the skin, the cornea and various mucosal surfaces. Conventionally, dissolving MAPs provide rapid drug release but have a limited drug-loading capacity. Hydrogel-forming MAPs can prolong drug release typically for no more than several weeks but often involve harsh manufacturing conditions, such as elevated temperatures above 60 °C for chemical crosslinking. For both types of MAPs, the drug release kinetics depends greatly on the physical properties of the polymers used. However, common polymers used for MAP formulation are very constrained in their…

  2. Very close Groundwork for this paper Cited by this paper Used in depth by this paper
    Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery
    R. Donnelly, M. McCrudden, A. Zaid Alkilani et al. · 2014 · PLoS ONE · cited 307 times · Not summarized yet

    Combines super-swelling hydrogel microneedles with lyophilised ibuprofen sodium wafers, a reservoir approach used in this paper.

    Abstract

    We describe, for the first time, hydrogel-forming microneedle arrays prepared from “super swelling” polymeric compositions. We produced a microneedle formulation with enhanced swelling capabilities from aqueous blends containing 20% w/w Gantrez S-97, 7.5% w/w PEG 10,000 and 3% w/w Na2CO3 and utilised a drug reservoir of a lyophilised wafer-like design. These microneedle-lyophilised wafer compositions were robust and effectively penetrated skin, swelling extensively, but being removed intact. In in vitro delivery experiments across excised neonatal porcine skin, approximately 44 mg of the model high dose small molecule drug ibuprofen sodium was delivered in 24 h, equating to 37% of the loadin…

  3. Very close Broader context
    Dissolving Polymeric Microneedles for Enhanced Transdermal Drug Delivery: Formulation Optimization, Characterization, and Permeation Studies
    Hiep X. Nguyen, B. Tran, Thao P. Nguyen et al. · 2026 · Molecular Pharmaceutics · Not summarized yet

    Optimizes dissolving polymeric microneedles for berberine chloride and salmon calcitonin rather than hydrogel-forming arrays delivering ibuprofen.

    Abstract

    This investigation aimed to fabricate and optimize dissolving microneedle patches composed of hydroxypropyl methylcellulose and polyvinylpyrrolidone for transdermal delivery of two model drugs: berberine chloride (BBR) and salmon calcitonin (sCT). Dissolving microneedles were prepared using the micromolding technique. The effects of polymer type, concentration, polymer blending ratios, and vacuum-assisted air bubble removal duration on microneedle morphology, mechanical strength, and rheological behavior were investigated. In vitro drug permeation and skin retention were evaluated using vertical diffusion cells with excised mouse skin. A vacuum duration of 15 min × 2 cycles was optimal for c…

  4. Very close Review Cites this paper
    Microneedle-Based Transdermal Drug Delivery: Recent Advances and Future Prospects
    B. Jeelani, Angamuthu Raja, S. Buvaneshwari et al. · 2026 · International Journal of Drug Delivery Technology · Not summarized yet

    Reviews microneedle types and design factors for transdermal delivery, including hydrogel-forming systems.

    Abstract

    Microneedle (MN) systems are emerging as versatile platforms that create micron-scale pathways across the stratum corneum while limiting stimulation of deeper pain receptors and blood vessels. This minimally invasive approach expands transdermal delivery beyond the small, moderately lipophilic molecules traditionally suited to passive patches and enables administration of peptides, proteins, vaccines, poorly soluble drugs, nucleic-acid formulations and locally acting dermatological agents. This review critically examines solid, coated, hollow, dissolving, separable and hydrogel-forming microneedles, with emphasis on how material selection, needle geometry, drug localization and manufacturing…

  5. Very close Review
    Dissolving Microneedle Patches: A Next- Generation Approach for Painless and Targeted Drug Delivery
    Priyanshi Singh, Akash Rawat, Vaibhav Rajoriya · 2026 · Journal of Advanced Pharmaceutical Sciences and Natural Products · Not summarized yet

    Surveys dissolving microneedle patches that deposit drug in skin, unlike this paper’s hydrogel-forming arrays and modified reservoirs.

    Abstract

    Dissolving microneedle patches (DMNPs) are an emerging transdermal platform designed to overcome the barrier function of the stratum corneum while retaining the convenience of a patch and avoiding the discomfort and sharps waste associated with conventional injections. In a DMNP, microscopic projections composed of water-soluble or biodegradable materials contain or carry the active pharmaceutical ingredient. After application, the projections penetrate the superficial skin layers and dissolve or disintegrate in response to tissue fluid, depositing the payload within the skin. This approach can improve access to compounds that show inadequate passive permeation, including selected peptides, …

  6. Very close Broader context
    Development of dissolving polymeric microneedles loaded with benzocaine nanocrystals as an effective intradermal drug delivery system.
    Ayman Alhaj Abbas, Omar Jabaiti, Sharif Abdelghany · 2026 · International journal of pharmaceutics · Not summarized yet

    Develops benzocaine-nanocrystal dissolving microneedles for intradermal delivery, rather than ibuprofen reservoirs paired with hydrogel-forming needles.

    Abstract

    The development of dissolving polymeric microneedles (DPMNs) loaded with drug nanocrystals is an innovative and minimally invasive approach for localized drug administration. In this work, benzocaine, a short-acting local anesthetic, was formulated into nanocrystals (BZ-NCs) and subsequently incorporated into polymeric microneedles. Several formulations of BZ-NCs were formulated via nanoprecipitation technique, utilizing ethanol as a solvent and varying aqueous concentrations of sodium lauryl sulfate (SLS), Polysorbate 80, or Poloxamer 188 as the antisolvent. The optimized formulation of BZ-NCs, which was developed utilizing 0.5% w/v SLS in the antisolvent phase, was assessed employing atten…

  7. Very close Groundwork for this paper Cited by this paper Used in depth by this paper
    Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery
    R. Donnelly, Thakur Raghu Raj Singh, M. Garland et al. · 2012 · Advanced Functional Materials · cited 680 times · Not summarized yet

    Introduces crosslinked, drug-free hydrogel microneedles that connect attached reservoirs to dermal circulation, the platform used here.

    Abstract

    Unique microneedle arrays prepared from crosslinked polymers, which contain no drug themselves, are described. They rapidly take up skin interstitial fluid upon skin insertion to form continuous, unblockable, hydrogel conduits from attached patch‐type drug reservoirs to the dermal microcirculation. Importantly, such microneedles, which can be fabricated in a wide range of patch sizes and microneedle geometries, can be easily sterilized, resist hole closure while in place, and are removed completely intact from the skin. Delivery of macromolecules is no longer limited to what can be loaded into the microneedles themselves and transdermal drug delivery is now controlled by the crosslink densit…

  8. Very close Review
    Sustainable Hydrogel‐Forming Microneedle‐Reservoir Patches for Transdermal Delivery of Hydrophilic Macromolecules: Biopolymers, Green Manufacturing and Translation
    Siddharth Mohanty, M. Aydogdu, Si-Jia Kang et al. · 2026 · Advancement of science · Not summarized yet

    Reviews hydrogel-forming microneedle-reservoir patches, focusing on hydrophilic biomacromolecules, manufacturing, and translation.

    Abstract

    ABSTRACT Hydrophilic biomacromolecules, including insulin, peptides, proteins and vaccine antigens, have transformed modern therapeutics, yet their delivery remains dominated by injections because the stratum corneum (SC) severely restricts passive transport of large and polar molecules. Microneedles have created a route through this barrier, but many existing systems remain limited by low loading capacity, burst release, weak dose control, microbiological quality requirements, short‐term stability, and poor manufacturing scalability. This review critically examines hydrogel‐forming microneedle (HFMN)‐reservoir patches as an emerging architecture for controlled transdermal biomacromolecule d…

Prior work it builds on

  1. Close Same method, another problem Used in depth by this paper
    Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Q. Anjani, A. D. Permana, Álvaro Cárcamo-Martínez et al. · 2020 · European journal of pharmaceutics and biopharmaceutics · cited 128 times · Not summarized yet

    Uses hydrogel-forming microneedles with lyophilised and other drug reservoirs to deliver tuberculosis drugs across skin.

    Abstract

    Current therapy of tuberculosis (TB) has several limitations, such as risk of liver injury and intestinal dysbiosis due to frequent oral administration of antibiotics. Transdermal administration could be used to improve antibiotic delivery for treatment of Mycobacterium tuberculosis infection. Therefore, we developed a novel approach, using hydrogel-forming microneedle (MN) arrays to transdermally deliver TB drugs, namely rifampicin, isoniazid, pyrazinamide and ethambutol, which have different physicochemical properties. These drugs were individually prepared into three types of drug reservoirs, including lyophilised tablets, directly compressed tablets and poly(ethylene glycol) tablets. For…

  2. Close Same method, another problem Used in depth by this paper
    Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin.
    Akmal Hidayat Bin Sabri, Qonita Kurnia Anjani, Emilia Utomo et al. · 2022 · International journal of pharmaceutics · cited 56 times · Not summarized yet

    Develops a dry drug reservoir paired with hydrogel-forming microneedles, applying the reservoir-patch design to cefazolin.

    Abstract

    Cefazolin (CFZ) is one of the most extensively used cephalosporins. This antibiotic exerts its bactericidal activity by interfering with bacterial cell wall formation, leading to bacteriolysis. CFZ is highly polar, resulting in the drug having poor oral bioavailability. Accordingly, the antibiotic is administered via intramuscular or intravenous injections, which are both painful and invasive. Due to these limitations, there is an impetus to explore alternative drug delivery platforms which offer a minimally invasive approach to delivery CFZ into and across the skin. The current work presents the development of a composite pharmaceutical system composed of hydrogel-forming microneedles (MNs)…

  3. Close Same method, another problem
    Microneedle-mediated delivery of donepezil: Potential for improved treatment options in Alzheimer's disease.
    Mary-Carmel Kearney, E. Caffarel-Salvador, Steven J. Fallows et al. · 2016 · European journal of pharmaceutics and biopharmaceutics · cited 123 times · Not summarized yet

    Evaluates hydrogel-forming microneedles and a drug-loaded reservoir for transdermal delivery of donepezil.

    Abstract

    Transdermal drug delivery is an attractive route of drug administration; however, there are relatively few marketed transdermal products. To increase delivery across the skin, strategies to enhance skin permeability are widely investigated, with microneedles demonstrating particular promise. Hydrogel-forming microneedles are inserted into the skin, and following dissolution of a drug loaded reservoir and movement of the drug through the created channels, the microneedle array is removed intact, and can then be readily and safely discarded. This study presents the formulation and evaluation of an integrated microneedle patch containing the Alzheimer's drug, donepezil hydrochloride. The integr…

  4. Close* Groundwork for this paper
    Microneedle-Mediated Transdermal and Intradermal Drug Delivery: Donnelly/Microneedle-Mediated Transdermal and Intradermal Drug Delivery
    R. Donnelly, Thakur Raghu Raj Singh, Desmond I. J. Morrow et al. · 2012 · cited 107 times · Not summarized yet

    Provides background on microneedle-mediated transdermal and intradermal delivery, the drug-delivery approach studied here.

  5. Close* Groundwork for this paper
    Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis.
    Xueming Wu, H. Todo, K. Sugibayashi · 2007 · Journal of Controlled Release · cited 115 times · Not summarized yet

    Investigates combining microneedle pretreatment with iontophoresis to enhance skin permeation, a physical enhancement strategy tested here.

Papers that cite it

  1. Close Same method, another problem
    Controlled release of amitriptyline via the transdermal route using SmartReservoirs and hydrogel-forming microneedles.
    Abraham M. Abraham, Amitha Simon, Q. Anjani et al. · 2025 · Biomaterials Advances · cited 7 times · Not summarized yet

    Uses modified drug reservoirs with hydrogel-forming microneedles to control transdermal delivery, studying amitriptyline rather than ibuprofen.

    Abstract

    SmartReservoirs (SRs) are novel drug reservoirs made from a cellulose-based matrix for hydrogel-forming microneedles (HF-MNs). SRs can incorporate drug molecules within a cellulose-based matrix in amorphous form. This significantly improves the solubility of poorly soluble drugs, which enhances drug delivery by allowing for rapid dissolution and absorption once the dosage form is administered. In contrast to improving the solubility of hydrophobic drugs, SRs might be used to modify the amorphous/crystalline properties of hydrophilic drugs, thus leading to a controlled release profile. Hence, SRs hold a promise as drug reservoirs for hydrophilic drugs and has not yet been investigated for suc…

  2. Close* Review
    Advances in dissolving microneedles-based drug delivery system for treating dermatological diseases
    Gang Chen, Jiaying Li, Qinglei Bu et al. · 2025 · Journal of Drug Delivery Science and Technology · cited 4 times · Not summarized yet

    Reviews dissolving microneedle delivery for dermatological diseases, a neighbouring microneedle platform.

  3. Close Broader context
    Citric acid-crosslinked carboxymethyl cellulose hydrogel microneedles enable gentle loading and rapid transdermal delivery of insulin.
    Man Zhang, Yuanpeng Wang · 2025 · International journal of pharmaceutics · cited 5 times · Not summarized yet

    Develops insulin-loaded, pH-responsive hydrogel microneedles, rather than reservoir-fed arrays delivering ibuprofen sodium.

    Abstract

    Transdermal insulin delivery using microneedle (MN) systems provides a promising, patient-friendly alternative to conventional subcutaneous injections. In this study, we developed a citric acid crosslinked carboxymethyl cellulose hydrogel microneedle (CMC-CA HMN) system capable of efficient insulin loading and rapid, pH-triggered release. Thermal esterification produced a CMC-CA hydrogel enriched with abundant carboxyl groups, facilitating electrostatic insulin loading under acidic conditions and immediate release at physiological pH. Fourier transform infrared (FTIR) spectroscopy confirmed successful ester crosslinking. The optimized hydrogel exhibited a high insulin loading capacity (8.7 m…

  4. Close* Review
    Advances in hydrogel-forming microneedle arrays: from functionalization to diverse application
    Yan-Hui Wang, Wenqiang Zhang, Yang-Zi Zhang et al. · 2026 · Trends in Analytical Chemistry (TrAC) · cited 1 time · Not summarized yet

    Surveys functionalization and applications of hydrogel-forming microneedle arrays, the platform used in this paper.

  5. Close Broader context
    Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System
    Priyanka Panchal, Snehal Daware, Yi Guo et al. · 2026 · AAPS PharmSciTech · cited 3 times · Not summarized yet

    Studies dissolving microneedles for semaglutide stability and delivery, not hydrogel-forming arrays with ibuprofen reservoirs.

    Abstract

    Glucagon-like peptide-1 agonists, especially Semaglutide (SMG), have revolutionized the management of diabetes and obesity, yet its clinical application is hindered by challenges in oral bioavailability and patient adherence to injectable formulations. Transdermal delivery offers a promising alternative, and this study explores dissolving microneedle (DMN) technology for SMG administration. PETOX is a water-soluble polymer utilized for the fabrication of dissolving microneedles and unique stabilization of SMG by incorporating L-arginine. Our study presents the first comprehensive investigation of L-arginine as an excipient in dissolving microneedles to enhance peptide integrity and stability…

How are these papers found?

We compare the title and abstract of this paper with those of every paper summarized on this site, and with the papers Semantic Scholar recommends, those it cites and those citing it (for a much-cited paper, its most recent citations and, from OpenAlex, the most cited ones). Among the prior work and the follow-ups, the papers that use each other in depth, a method it uses and the much-cited follow-ups come a little higher. The levels (very close, close, related) come from the similarity of the texts, not from a judgment of quality; * marks a paper without an abstract, compared by its title. The sentence under a paper is written by an AI from the two abstracts: check it in the papers. A paper marked not relevant by three readers leaves the list.

Updated on 19 November 2026.

The illustrated guide to the papers around a paper